-
Data downloaded via parachute from a NASA super-pressure balloon
Authors:
Ellen L. Sirks,
Richard Massey,
Ajay S. Gill,
Jason Anderson,
Steven J. Benton,
Anthony M. Brown,
Paul Clark,
Joshua English,
Spencer W. Everett,
Aurelien A. Fraisse,
Hugo Franco,
John W. Hartley,
David Harvey,
Bradley Holder,
Andrew Hunter,
Eric M. Huff,
Andrew Hynous,
Mathilde Jauzac,
William C. Jones,
Nikky Joyce,
Duncan Kennedy,
David Lagattuta,
Jason S. -Y. Leung,
Lun Li,
Stephen Lishman
, et al. (18 additional authors not shown)
Abstract:
In April to May 2023, the superBIT telescope was lifted to the Earth's stratosphere by a helium-filled super-pressure balloon, to acquire astronomical imaging from above (99.5% of) the Earth's atmosphere. It was launched from New Zealand then, for 40 days, circumnavigated the globe five times at a latitude 40 to 50 degrees South. Attached to the telescope were four 'DRS' (Data Recovery System) cap…
▽ More
In April to May 2023, the superBIT telescope was lifted to the Earth's stratosphere by a helium-filled super-pressure balloon, to acquire astronomical imaging from above (99.5% of) the Earth's atmosphere. It was launched from New Zealand then, for 40 days, circumnavigated the globe five times at a latitude 40 to 50 degrees South. Attached to the telescope were four 'DRS' (Data Recovery System) capsules containing 5 TB solid state data storage, plus a GNSS receiver, Iridium transmitter, and parachute. Data from the telescope were copied to these, and two were dropped over Argentina. They drifted 61 km horizontally while they descended 32 km, but we predicted their descent vectors within 2.4 km: in this location, the discrepancy appears irreducible below 2 km because of high speed, gusty winds and local topography. The capsules then reported their own locations to within a few metres. We recovered the capsules and successfully retrieved all of superBIT's data - despite the telescope itself being later destroyed on landing.
△ Less
Submitted 14 November, 2023;
originally announced November 2023.
-
Extending inferences from a cluster randomized trial to a target population
Authors:
Issa J. Dahabreh,
Sarah E. Robertson,
Jon A. Steingrimsson,
Stefan Gravenstein,
Nina Joyce
Abstract:
We describe methods that extend (generalize or transport) causal inferences from cluster randomized trials to a target population of clusters, under a general nonparametric model that allows for arbitrary within-cluster dependence. We propose doubly robust estimators of potential outcome means in the target population that exploit individual-level data on covariates and outcomes to improve efficie…
▽ More
We describe methods that extend (generalize or transport) causal inferences from cluster randomized trials to a target population of clusters, under a general nonparametric model that allows for arbitrary within-cluster dependence. We propose doubly robust estimators of potential outcome means in the target population that exploit individual-level data on covariates and outcomes to improve efficiency and are appropriate for use with machine learning methods. We illustrate the methods using a cluster randomized trial of influenza vaccination strategies conducted in 818 nursing homes nested in a cohort of 4,475 trial-eligible Medicare-certified nursing homes.
△ Less
Submitted 28 March, 2022;
originally announced March 2022.
-
Estimating subgroup effects in generalizability and transportability analyses
Authors:
Sarah E. Robertson,
Jon A. Steingrimsson,
Nina R. Joyce,
Elizabeth A. Stuart,
Issa J. Dahabreh
Abstract:
Methods for extending -- generalizing or transporting -- inferences from a randomized trial to a target population involve conditioning on a large set of covariates that is sufficient for rendering the randomized and non-randomized groups exchangeable. Yet, decision-makers are often interested in examining treatment effects in subgroups of the target population defined in terms of only a few discr…
▽ More
Methods for extending -- generalizing or transporting -- inferences from a randomized trial to a target population involve conditioning on a large set of covariates that is sufficient for rendering the randomized and non-randomized groups exchangeable. Yet, decision-makers are often interested in examining treatment effects in subgroups of the target population defined in terms of only a few discrete covariates. Here, we propose methods for estimating subgroup-specific potential outcome means and average treatment effects in generalizability and transportability analyses, using outcome model-based (g-formula), weighting, and augmented weighting estimators. We consider estimating subgroup-specific average treatment effects in the target population and its non-randomized subset, and provide methods that are appropriate both for nested and non-nested trial designs. As an illustration, we apply the methods to data from the Coronary Artery Surgery Study to compare the effect of surgery plus medical therapy versus medical therapy alone for chronic coronary artery disease in subgroups defined by history of myocardial infarction.
△ Less
Submitted 28 September, 2021;
originally announced September 2021.
-
Center-specific causal inference with multicenter trials: reinterpreting trial evidence in the context of each participating center
Authors:
Sarah E. Robertson,
Jon A. Steingrimsson,
Nina R. Joyce,
Elizabeth A. Stuart,
Issa J. Dahabreh
Abstract:
In multicenter randomized trials, when effect modifiers have a different distribution across centers, comparisons between treatment groups that average over centers may not apply to any of the populations underlying the individual centers. Here, we describe methods for reinterpreting the evidence produced by a multicenter trial in the context of the population underlying each center. We describe h…
▽ More
In multicenter randomized trials, when effect modifiers have a different distribution across centers, comparisons between treatment groups that average over centers may not apply to any of the populations underlying the individual centers. Here, we describe methods for reinterpreting the evidence produced by a multicenter trial in the context of the population underlying each center. We describe how to identify center-specific effects under identifiability conditions that are largely supported by the study design and when associations between center membership and the outcome may be present, given baseline covariates and treatment ("center-outcome associations"). We then consider an additional condition of no center-outcome associations given baseline covariates and treatment. We show that this condition can be assessed using the trial data; when it holds, center-specific treatment effects can be estimated using analyses that completely pool information across centers. We propose methods for estimating center-specific average treatment effects, when center-outcome associations may be present and when they are absent, and describe approaches for assessing whether center-specific treatment effects are homogeneous. We evaluate the performance of the methods in a simulation study and illustrate their implementation using data from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis trial.
△ Less
Submitted 25 April, 2021; v1 submitted 12 April, 2021;
originally announced April 2021.
